학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 6건 | 목록
1~20
Academic Journal
Schoenfeld, Jonathan D ; Giobbie-Hurder, Anita ; Ranasinghe, Srinika ; Kao, Katrina Z ; Lako, Ana ; Tsuji, Junko ; Liu, Yang ; Brennick, Ryan C ; Gentzler, Ryan D ; Lee, Carrie ; Hubbard, Joleen ; Arnold, Susanne M ; Abbruzzese, James L ; Jabbour, Salma K ; Uboha, Nataliya V ; Stephans, Kevin L ; Johnson, Jennifer M ; Park, Haeseong ; Villaruz, Liza C ; Sharon, Elad ; Streicher, Howard ; Ahmed, Mansoor M ; Lyon, Hayley ; Cibuskis, Carrie ; Lennon, Niall ; Jhaveri, Aashna ; Yang, Lin ; Altreuter, Jennifer ; Gunasti, Lauren ; Weirather, Jason L ; Mak, Raymond H ; Awad, Mark M ; Rodig, Scott J ; Chen, Helen X ; Wu, Catherine J ; Monjazeb, Arta M ; Hodi, F Stephen
In The Lancet Oncology February 2022 23(2):279-291
Academic Journal
Monjazeb, Arta M; Giobbie-Hurder, Anita; Lako, Ana; Thrash, Emily M; Brennick, Ryan C; Kao, Katrina Z; Manuszak, Claire; Gentzler, Ryan D; Tesfaye, Anteneh; Jabbour, Salma K; Alese, Olatunji B; Rahma, Osama E; Cleary, James M; Sharon, Elad; Mamon, Harvey J; Cho, May; Streicher, Howard; Chen, Helen X; Ahmed, Mansoor M; Mariño-Enríquez, Adrian; Kim-Schulze, Seunghee; Gnjatic, Sacha; Maverakis, Emanual; Marusina, Alina I; Merleev, Alexander A; Severgnini, Mariano; Pfaff, Kathleen L; Lindsay, James; Weirather, Jason L; Ranasinghe, Srinika; Spektor, Alexander; Rodig, Scott J; Hodi, F Stephen; Schoenfeld, Jonathan D
Clinical Cancer Research, vol 27, iss 9
Academic Journal
Zhou J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Li J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Guleria I; Tissue Typing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Chen T; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Giobbie-Hurder A; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Stevens J; Tissue Typing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Gupta M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Wu X; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Brennick RC; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Manos MP; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. stephen_hodi@dfci.harvard.edu.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. stephen_hodi@dfci.harvard.edu.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. stephen_hodi@dfci.harvard.edu.; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. stephen_hodi@dfci.harvard.edu.
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Academic Journal
Barroso-Sousa R; Oncology Center, Hospital Sírio-Libanês, Brasília, Brazil.; Forman J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA.; Collier K; Ohio State University College of Medicine, Columbus, OH.; Weber ZT; Ohio State University College of Medicine, Columbus, OH.; Jammihal TR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Kao KZ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Richardson ET 3rd; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Keenan T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Cohen O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Manos MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Brennick RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Dillon DA; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Attaya V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; O'Meara T; Internal Medicine, Brigham and Women's Hospital, Boston, MA.; Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Rodig S; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Mittendorf EA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Divison of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA.; Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Stover DG; Ohio State University College of Medicine, Columbus, OH.; Shukla SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA.; Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE
Academic Journal
Monjazeb AM; Giobbie-Hurder A; Lako A; Thrash EM; Brennick RC; Kao KZ; Manuszak C; Gentzler RD; Tesfaye A; Jabbour SK; Alese OB; Rahma OE; Cleary JM; Sharon E; Mamon HJ; Cho M; Streicher H; Chen HX; Ahmed MM; Mariño-Enríquez A; Kim-Schulze S; Gnjatic S; Maverakis E; Marusina AI; Merleev AA; Severgnini M; Pfaff KL; Lindsay J; Weirather JL; Ranasinghe S; Spektor A; Rodig SJ; Hodi FS; Schoenfeld JD
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Weirather JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Manos M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Quattrochi BJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Brennick RC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bowling P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bailey N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Magarace L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Haq R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Izar B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Giobbie-Hurder A; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Brennick, Ryan C
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어